HCV / Hepatitis

>

Latest News

Bone Changes and Inflammation After Hepatitis C Cure: 18-Month Outcomes
Bone Changes and Inflammation After Hepatitis C Cure: 18-Month Outcomes

September 17th 2025

Vincent Lo Re, MD, MSCE, FISPE, reviews HR-pQCT findings, IL-18 and TNF-α declines, and guidance for clinicians.

Excision’s EBT-107 CRISPR Candidate Reduces HBV DNA and Suppresses New Integration in Preclinical Studies
Excision’s EBT-107 CRISPR Candidate Reduces HBV DNA and Suppresses New Integration in Preclinical Studies

September 15th 2025

First Patient Enrolled in Phase 3 Study for Hepatitis D Treatment
First Patient Enrolled in Phase 3 Study for Hepatitis D Treatment

September 8th 2025

Top 5 Infectious Disease News Stories Week of August 16-23
Top 5 Infectious Disease News Stories Week of August 16-23

August 23rd 2025

Cumulative HBsAg/HBV DNA Ratio Predicts Disease Progression in Immune-Tolerant Hepatitis B
Cumulative HBsAg/HBV DNA Ratio Predicts Disease Progression in Immune-Tolerant Hepatitis B

August 21st 2025

More News

© 2025 MJH Life Sciences

All rights reserved.